Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily R Mason

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Alzheimer'S & Dementia (New York, N. Y.)|April 18, 2022
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathologyFrances M Potjewyd, Joel K Annor-Gyamfi, Jeffrey Aubé, et al.
Alzheimer'S & Dementia (New York, N. Y.)|November 29, 2023
SHIP1 therapeutic target enablement: Identification and evaluation of inhibitors for the treatment of late-onset Alzheimer's diseaseCynthia D Jesudason, Emily R Mason, Shaoyou Chu, et al.
Journal of Medicinal Chemistry|April 30, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Biorxiv : the Preprint Server for Biology|January 9, 2026
Optimization and Characterization of SHIP1 Ligands for Cellular Target Engagement and Activity in Alzheimer's Disease ModelsCynthia D Jesudason, Claudia Rangel-Barajas, Colin J Beach, et al.
Pageof 2